186 related articles for article (PubMed ID: 35582982)
1. The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials.
Cho K; Park S; Koyanagi A; Jacob L; Yon DK; Lee SW; Kim MS; Kim SU; Kim BK; Shin JI; Smith L
Obes Rev; 2022 Sep; 23(9):e13464. PubMed ID: 35582982
[TBL] [Abstract][Full Text] [Related]
2. Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials.
Peng X; Li J; Zhao H; Lai J; Lin J; Tang S
BMC Endocr Disord; 2022 Apr; 22(1):95. PubMed ID: 35399069
[TBL] [Abstract][Full Text] [Related]
3. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.
Kwon OY; Choi JY; Jang Y
J Med Internet Res; 2023 Jan; 25():e37487. PubMed ID: 36689264
[TBL] [Abstract][Full Text] [Related]
4. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE
BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541
[TBL] [Abstract][Full Text] [Related]
5. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.
Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD
Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444
[TBL] [Abstract][Full Text] [Related]
6. Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression.
Orci LA; Gariani K; Oldani G; Delaune V; Morel P; Toso C
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1398-411. PubMed ID: 27155553
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of randomized controlled trials to evaluate plant-based omega-3 polyunsaturated fatty acids in nonalcoholic fatty liver disease patient biomarkers and parameters.
Moore E; Patanwala I; Jafari A; Davies IG; Kirwan RP; Newson L; Mazidi M; Lane KE
Nutr Rev; 2024 Jan; 82(2):143-165. PubMed ID: 37290426
[TBL] [Abstract][Full Text] [Related]
8. Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials.
Wang Y; Yi H; Sun W; Yu H; Tao W; Yu X; Jia D; Liu Y; Pandol SJ; Li L
Drugs; 2024 Apr; 84(4):425-439. PubMed ID: 38478331
[TBL] [Abstract][Full Text] [Related]
9. Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Hall RL; George ES; Tierney AC; Reddy AJ
Adv Nutr; 2023 May; 14(3):475-499. PubMed ID: 36796436
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD): Evidence from an umbrella review of meta-analysis on randomized controlled trials.
Wang MY; Prabahar K; Găman MA; Zhang JL
J Dig Dis; 2023; 24(6-7):380-389. PubMed ID: 37503812
[TBL] [Abstract][Full Text] [Related]
11. Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis.
Li S; Duan F; Li S; Lu B
Ann Hepatol; 2024; 29(2):101174. PubMed ID: 38579127
[TBL] [Abstract][Full Text] [Related]
12. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Tang G; Zhang L; Tao J; Wei Z
Phytother Res; 2021 Aug; 35(8):4183-4193. PubMed ID: 33728708
[TBL] [Abstract][Full Text] [Related]
13. Weight reduction for non-alcoholic fatty liver disease.
Peng L; Wang J; Li F
Cochrane Database Syst Rev; 2011 Jun; (6):CD003619. PubMed ID: 21678341
[TBL] [Abstract][Full Text] [Related]
14. Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review.
Mann JP; Tang GY; Nobili V; Armstrong MJ
Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1457-1476.e7. PubMed ID: 29857146
[TBL] [Abstract][Full Text] [Related]
15. Statins for the Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis.
Dai W; Xu B; Li P; Weng J
Am J Ther; 2023 Jan-Feb 01; 30(1):e17-e25. PubMed ID: 36608070
[TBL] [Abstract][Full Text] [Related]
16. Effects of various interventions on non-alcoholic fatty liver disease (NAFLD): A systematic review and network meta-analysis.
Wang X; Jin X; Li H; Zhang X; Chen X; Lu K; Chu C
Front Pharmacol; 2023; 14():1180016. PubMed ID: 37063273
[No Abstract] [Full Text] [Related]
17. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Fan S; Shi X; Yao J; Zhong M; Feng P
Rev Esp Enferm Dig; 2020 Aug; 112(8):627-635. PubMed ID: 32496108
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
[TBL] [Abstract][Full Text] [Related]
20. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
Africa JA; Newton KP; Schwimmer JB
Dig Dis Sci; 2016 May; 61(5):1375-86. PubMed ID: 27041377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
